These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 31487705

  • 21. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grünert A.
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [Abstract] [Full Text] [Related]

  • 22. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [Abstract] [Full Text] [Related]

  • 23. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ, Mon C, Heras M, Guevara P, Garcia MC, Sanchez R, Velasco S, Alvarez-Ude F.
    J Nephrol; 2004 May; 17(5):721-7. PubMed ID: 15593041
    [Abstract] [Full Text] [Related]

  • 24. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M, Schou M, Tuxen CD, Kistorp CN, Hildebrandt PR, Gustafsson F, Faber J, Goetze JP, Gustafsson I.
    Am J Cardiol; 2012 Aug 15; 110(4):552-7. PubMed ID: 22579083
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Rogers RK, May HT, Anderson JL, Muhlestein JB.
    Am Heart J; 2009 Nov 15; 158(5):777-83. PubMed ID: 19853697
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.
    Nephrol Dial Transplant; 2009 Jun 15; 24(6):1962-9. PubMed ID: 19237403
    [Abstract] [Full Text] [Related]

  • 27. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.
    Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T.
    Circ J; 2007 May 15; 71(5):631-5. PubMed ID: 17456983
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J.
    Scand J Clin Lab Invest; 2004 May 15; 64(7):667-76. PubMed ID: 15513324
    [Abstract] [Full Text] [Related]

  • 30. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.
    J Cardiovasc Magn Reson; 2007 May 15; 9(5):749-58. PubMed ID: 17891611
    [Abstract] [Full Text] [Related]

  • 31. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W.
    JAMA; 2003 Jul 16; 290(3):353-9. PubMed ID: 12865376
    [Abstract] [Full Text] [Related]

  • 32. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS, Murakami MM, Pearce LA, Herzog CA.
    Clin Chem; 2004 Dec 16; 50(12):2279-85. PubMed ID: 15364888
    [Abstract] [Full Text] [Related]

  • 33. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism.
    Tulevski II, ten Wolde M, van Veldhuisen DJ, Mulder JW, van der Wall EE, Büller HR, Mulder BJ.
    Int J Cardiol; 2007 Mar 20; 116(2):161-6. PubMed ID: 16814410
    [Abstract] [Full Text] [Related]

  • 34. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 20; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 35. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane.
    Laveborn E, Lindmark K, Skagerlind M, Stegmayr B.
    Int J Artif Organs; 2015 Feb 20; 38(2):69-75. PubMed ID: 25744196
    [Abstract] [Full Text] [Related]

  • 36. Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study.
    Nakamura S, Takano H, Matsuda J, Chinen D, Kitamura M, Murai K, Asai K, Yasutake M, Takayama M, Shimizu W.
    BMJ Open; 2014 Sep 17; 4(9):e005968. PubMed ID: 25231494
    [Abstract] [Full Text] [Related]

  • 37. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

  • 38. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
    Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R, Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators.
    Circulation; 2012 Jan 17; 125(2):280-8. PubMed ID: 22139751
    [Abstract] [Full Text] [Related]

  • 39. High-Sensitive Cardiac Troponin T for Prediction of Cardiovascular Outcomes in Stable Maintenance Hemodialysis Patients: A 3-Year Prospective Study.
    Sun L, Wang Y, Zhang N, Xie X, Ding M, Guo H, Li F, Wang X.
    Kidney Blood Press Res; 2021 Jan 17; 46(4):484-494. PubMed ID: 34167109
    [Abstract] [Full Text] [Related]

  • 40. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.
    J Am Heart Assoc; 2017 Jul 05; 6(7):. PubMed ID: 28679558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.